期刊档案 · Nursing-Oncology (nursing)

Technical Innovations and Patient Support in Radiation Oncology

ISSN 2405-6324 · Elsevier · Netherlands

Technical Innovations and Patient Support in Radiation Oncology 中科院新锐版 医学 3区,影响因子 2(官网公布),完全开放获取,APC 约 1,410 美元,近 24 个月 101 篇文章投稿到接收中位 89 天,2025 年发文 73 篇,ESCI、Scopus 收录。

影响因子2期刊官网公布的最新值
中科院分区医学 3区2026 年新锐版大类
审稿周期89 天投稿到接收中位数 · 近 24 个月 101 篇文章 · PubMed
版面费1,410 USD完全开放获取
录用比例—暂无反馈
年发文量73 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Technical Innovations and Patient Support in Radiation Oncology 由 Elsevier 出版,属中科院医学大类。按 OpenAlex 近年发文统计,该刊主要发表 Advanced Radiotherapy Techniques、Advances in Oncology and Radiotherapy、Radiation Therapy and Dosimetry 等主题的论文,这 3 个主题约占 48.5%,主导子领域为 Radiology, Nuclear Medicine and Imaging、Pulmonary and Respiratory Medicine。(根据 OpenAlex 主题统计与中科院分区数据生成)

An Official Journal of The European Society for Radiotherapy and OncologyTechnical Innovations & Patient Support in Radiation Oncology is an international, open access journal which brings together technology and patient care in the field of radiation oncology. The journal encompasses all topics of importance to radiation therapists, nurses and allied health professionals, including:* Treatment planning and workflows * Treatment delivery * Treatment verification * Patient care * Supportive care * Psycho-oncology * Education and training * Patient advocacy * Policy development and management * Patient reported outcome measures * Risk management * Radiotherapy quality management and control * Radiotherapy audit * Radiotherapy workflow management * PersonalisationThe journal publishes original research articles, case reports, practice development and health evaluation articles, review articles, short communications, technical notes, case series and reports, and correspondence.

摘自期刊官网 Aims & Scope

研究方向(LetPub):Nursing-Oncology (nursing)

主编 Aileen Duffton出版商官网

编委会国家分布:未见中国大陆编委;主要国家 澳大利亚 7、荷兰 6、英国 5、加拿大 5、爱尔兰 4(共 39 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Advanced Radiotherapy TechniquesPhysics and Astronomy27%
  2. Advances in Oncology and RadiotherapyMedicine14.1%
  3. Radiation Therapy and DosimetryMedicine7.4%
  4. Prostate Cancer Diagnosis and TreatmentMedicine5.6%
  5. Lung Cancer Diagnosis and TreatmentMedicine5.5%
  6. Head and Neck Cancer StudiesMedicine4%
  7. Management of metastatic bone diseaseMedicine4%
  8. Radiology practices and educationMedicine3.9%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)医学 3 区
类别学科分区
大类医学3 区
小类肿瘤学ONCOLOGY3 区
小类核医学RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING3 区

Top 期刊:否综述期刊:未标注

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布)
2出版商官网 ·
CiteScore 2026-06
3.6LetPub ·
CiteScore(出版商公布)
3.6出版商官网 ·
SJR 2026-06
0.62LetPub ·
SNIP 2026-06
0.89LetPub ·
h-index
27OpenAlex ·
i10-index
101OpenAlex ·
两年平均被引
1.32OpenAlex ·
自引率
15%LetPub ·
Gold OA 文章占比
100%LetPub ·

发文规模

年文章数
67LetPub ·

逐年发文量 OpenAlex 统计 · 累计 434 篇 · 当年数据不完整

年份发文量其中 OA被引
2026656512
2025737372
20246565183
20233535187
20225252669
20214747618

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

89 天投稿到接收中位数 · P25–P75 72 天 – 123 天

接收到上线
中位数 2 天(101 篇)
投稿到上线
中位数 94 天
样本
101 篇有投稿与接收日期的文章(窗口内共 158 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
18 WeeksLetPub ·
投稿到首次决定
3 天出版商官网 ·
外审后首次决定
34 天出版商官网 ·
投稿到接收
92 天出版商官网 ·
接收到发表
4 天出版商官网 ·
投稿到发表(期刊自报)
约 14 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJUSD 1,410有CC BY、CC BY-NC-ND
OpenAlexUSD 1,410 / EUR 1,290 / GBP 1,130 / JPY 174,880——
LetPubEUR 1,290有—
出版商官网USD 1,890——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

征稿中的专刊1 个,按截稿日期
  1. Highlights of Brachytherapy - 2026截稿
出版商官网
投稿准备要点2 项,摘自作者指南
摘要
≤ 250 词
关键词
≥ 1 个
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型16 种,含篇幅限制
  1. case report1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…正文 ≤ 1,500 词
  2. case reports and case series5. Case reports and case series未说明篇幅
  3. correspondence7. Correspondence未说明篇幅
  4. guidelines / delphi consensus recommendations4. Guidelines / Delphi consensus recommendations (5000 words max., excluding the reference list; note: for exceptional surveys only, aim for 3000 words)未说明篇幅
  5. original research article1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…未说明篇幅
  6. practice development and health evaluation articles6. Practice development and health evaluation articles (max. 2500 words)未说明篇幅
  7. research article1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…未说明篇幅
  8. research articles1. Research articles (max. 3000 words)未说明篇幅
  9. review1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…未说明篇幅
  10. review article1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…未说明篇幅
  11. review articles3. Review articles (max. 5000 words, excluding references)未说明篇幅
  12. short communication1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…未说明篇幅
  13. short communications and technical notes2. Short communications and technical notes (max. 2000 words)未说明篇幅
  14. survey1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…正文 ≤ 3,000 词
  15. systematic review1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…未说明篇幅
  16. technical note1. Research articles (max. 3000 words)Research articles should describe original scientific work which falls within the scope of the journal. Articles should in…未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、出版伦理、许可与版权、开放获取、同行评审、预印本、试验注册 / 报告规范
AI 使用 Declaration of generative AI use

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

原文 ↗出版商官网 ·
作者资格 Group authorship

集体署名必须在投稿时于标题页声明,通讯作者需协调所有相关沟通。 模型中文摘要

Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…

原文 ↗出版商官网 ·
利益冲突 Declaration of competing interests

所有作者必须披露可能不当影响其工作的财务和个人关系,并完成声明工具。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …

原文 ↗出版商官网 ·
出版伦理

作者必须遵守爱思唯尔出版伦理政策中规定的伦理准则。 模型中文摘要

Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.

原文 ↗出版商官网 ·
许可与版权 License options

作者将获得开放获取用户许可选项,建议在选择前审查这些选项及资助机构的许可要求。 模型中文摘要

Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.

原文 ↗出版商官网 ·
开放获取 Open access

本刊引导作者参阅开放获取信息页面以了解开放获取选项。 模型中文摘要

We refer you to our open access information page to learn about open access options for this journal.

原文 ↗出版商官网 ·
同行评审 Peer review

本刊采用单盲同行评审,稿件通常由至少两名审稿人评审,编辑作出最终决定。 模型中文摘要

This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…

原文 ↗出版商官网 ·
预印本 Preprints

作者可按爱思唯尔政策分享预印本,且本刊提供SSRN免费预印本发布服务。 模型中文摘要

Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …

原文 ↗出版商官网 ·
试验注册 / 报告规范 Study design and reporting guidelines

本刊要求按研究类型提交相应清单(如CONSORT、STROBE等),并要求临床试验注册。 模型中文摘要

Technical Innovations and Patient Support in Radiation Oncology recommends consulting the relevant study design and reporting guidelines before preparing your manuscript. Technical Innovations and Patient Support in Radiation Oncology requires a completed checklist as part of your submission, for the following study types: • Randomised trials - CONSORT • Observational studies - STROBE • Clinical G…

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Elsevier
出版国家或地区
Netherlands
出版语言
English
ISSN
2405-6324
学会 / 主办单位
European Society for Radiotherapy and Oncology
官方链接

常见问题

关于 Technical Innovations and Patient Support in Radiation Oncology 的常见问题

Technical Innovations and Patient Support in Radiation Oncology 是中科院几区期刊?

2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。

Technical Innovations and Patient Support in Radiation Oncology 的影响因子是多少?

期刊官网公布的影响因子为 2,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 3.6,h-index 为 27。

Technical Innovations and Patient Support in Radiation Oncology 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)101 篇已发表文章登记的日期,投稿到接收的中位数为 89 天(四分位 72–123 天);投稿社区反馈的平均审稿速度为约 18 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Technical Innovations and Patient Support in Radiation Oncology 的投稿格式要求是什么?

据期刊作者指南:摘要:≤ 250 词;关键词:≥ 1 个。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Technical Innovations and Patient Support in Radiation Oncology 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 39 位编委中,没有中国大陆学者;人数最多的国家是 澳大利亚(7 位)、荷兰(6 位)、英国(5 位)。统计按编委会页面列出的机构国家计,仅供参考。

Technical Innovations and Patient Support in Radiation Oncology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Technical Innovations and Patient Support in Radiation Oncology 被 ESCI、Scopus、DOAJ 收录。

Technical Innovations and Patient Support in Radiation Oncology 是开放获取期刊吗?版面费多少?

Technical Innovations and Patient Support in Radiation Oncology 为完全开放获取。APC 约 1,410 美元。

来源与更新

本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。